SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                               ------------------


                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE

                         SECURITIES EXCHANGE ACT OF 1934



      Date of Report (Date of earliest event reported) January 12, 2000



                         Curative Health Services, Inc.
             (Exact name of registrant as specified in its charter)



 Minnesota                          000-19370                       41-1503914
(State or other jurisdiction       (Commission File Number)        (IRS Employer
 of incorporation)                                           Identification No.)



 150 Motor Parkway, Hauppauge, NY                                   11788-5145
(Address of principal executive offices)                           (Zip code)



     Registrant's telephone number, including area code: (516)232-7000



                                NOT APPLICABLE
    (Former name or former address, if changed since last report.)

                                       1
<PAGE>


Item 5.  Other Events.

As previously  disclosed in the Company's  Form 10-Q for the quarter ended March
31, 1999,  in April 1999  Curative  Health  Services,  Inc.  received a document
subpoena from the Office of Inspector General ("OIG") of the U.S.  Department of
Health and Human Services,  Region II (New York, NY). The subpoena  directed the
Company  to  produce a broad  range of  documents  from  January  1, 1993 to the
present  relating  to various  areas  including,  among  others,  the Wound Care
Centers,  wound care  treatment  programs and general  business  practices.  The
subpoena  stated that it had been  delivered in  connection  with a "Health Care
Investigation".  In response to that subpoena, the Company has furnished a large
number of documents to the OIG.

The Company has learned that this "Health Care  Investigation"  relates to a qui
tam action filed under seal in the United States District Court for the Southern
District of New York in 1998.  Pursuant to a court order  entered on January 11,
2000,  the seal under which this action was filed was  modified  to, among other
things,  permit the Company to disclose the  allegations in the complaint in its
periodic filings with the Securities and Exchange  Commission and as required to
fulfill its disclosure obligations under federal and state securities laws.

The  complaint  was filed by a  "whistleblower"  relator under the federal civil
False Claims Act and names the Company and hospitals with which it does business
as defendants.  The complaint alleges,  among other things,  that the defendants
violated the "anti-kickback"  statute in part because a portion of the Company's
fee was based on the  number of new  patients  seen in the  wound  care  centers
managed  by the  Company;  engaged  in  prohibited  self-referral  transactions;
improperly  billed  Medicare  for costs and  services  not covered by  Medicare;
double-billed  Medicare for professional services; and submitted false claims to
Medicare.  Certain of the  allegations  are similar to the  allegations  made in
United  States ex. Rel.  Joseph  "Mickey"  Parslow v.  Columbia/HCA  Health Care
Corporation   and   Curative   Health    Services,    Inc.,   Civil   Case   No.
98-1260-civ-T-23F,  in the  Federal  District  Court for the Middle  District of
Florida,  Tampa Division, a qui tam action previously disclosed in the Company's
Form 10-Q for the quarter  ended March 31, 1999.  The  complaint in the Southern
District of New York action asserts that, as a result of the allegedly  wrongful
conduct,  the United States suffered  damages and that the defendants are liable
to the United  States for three  times the amount of the  alleged  damages  plus
civil penalties of up to $10,000 per false claim.

The United  States has not yet decided  whether to intervene in the New York qui
tam action.  If it does not, then the plaintiff relator may pursue the claims on
his/her own or may withdraw the complaint.

The  Company  disagrees  with  the  characterizations  in the  complaint  of its
contractual  arrangements,  its  services,  and the fees it  charges  for  those
services,  and intends to defend itself  vigorously  in this action.  An adverse
result  in this qui tam  action  could  have a  material  adverse  effect on the
Company's business, financial condition and/or results of operations.

                                       2
<PAGE>


Item 7.  Financial Statements and Exhibits

(a) (b)  No financial statements or proforma financial information filed herein.

(c)      No exhibits are filed as part of this Report.

                                       3
<PAGE>


                                   SIGNATURES



Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned, thereunto duly authorized.




                                   Curative Health Services, Inc.
                                  (Registrant)



Date:  January 12, 2000            By:  /s/John C. Prior
                                        --------------------------------
                                        John C. Prior
                                        Senior Vice President/Finance and CFO
[{"type": "8-K", "sequence": "1", "description": "8-K", "secsgml_size_bytes": 5494}]
{"company-data": {"conformed-name": "CURATIVE HEALTH SERVICES INC", "cik": "0000874212", "assigned-sic": "8093", "irs-number": "411503914", "state-of-incorporation": "MN", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-19370", "film-number": "506613"}, "business-address": {"street1": "150 MOTOR PARKWAY", "city": "HAUPPAUGE", "state": "NY", "zip": "11788-5145", "phone": "5162327000"}, "mail-address": {"street1": "150 MOTOR PARKWAY", "city": "HAUPPAUGE", "state": "NY", "zip": "117885145"}, "former-company": {"former-conformed-name": "CURATIVE TECHNOLOGIES INC /MN", "date-changed": "19930328"}}
SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                               ------------------

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE

                         SECURITIES EXCHANGE ACT OF 1934

      Date of Report (Date of earliest event reported) January 12, 2000

                         Curative Health Services, Inc.
             (Exact name of registrant as specified in its charter)

 Minnesota                          000-19370                       41-1503914
(State or other jurisdiction       (Commission File Number)        (IRS Employer
 of incorporation)                                           Identification No.)

 150 Motor Parkway, Hauppauge, NY                                   11788-5145
(Address of principal executive offices)                           (Zip code)

     Registrant's telephone number, including area code: (516)232-7000

                                NOT APPLICABLE
    (Former name or former address, if changed since last report.)

                                       1
Item 5.  Other Events.

As previously  disclosed in the Company's  Form 10-Q for the quarter ended March
31, 1999,  in April 1999  Curative  Health  Services,  Inc.  received a document
subpoena from the Office of Inspector General ("OIG") of the U.S.  Department of
Health and Human Services,  Region II (New York, NY). The subpoena  directed the
Company  to  produce a broad  range of  documents  from  January  1, 1993 to the
present  relating  to various  areas  including,  among  others,  the Wound Care
Centers,  wound care  treatment  programs and general  business  practices.  The
subpoena  stated that it had been  delivered in  connection  with a "Health Care
Investigation".  In response to that subpoena, the Company has furnished a large
number of documents to the OIG.

The Company has learned that this "Health Care  Investigation"  relates to a qui
tam action filed under seal in the United States District Court for the Southern
District of New York in 1998.  Pursuant to a court order  entered on January 11,
2000,  the seal under which this action was filed was  modified  to, among other
things,  permit the Company to disclose the  allegations in the complaint in its
periodic filings with the Securities and Exchange  Commission and as required to
fulfill its disclosure obligations under federal and state securities laws.

The  complaint  was filed by a  "whistleblower"  relator under the federal civil
False Claims Act and names the Company and hospitals with which it does business
as defendants.  The complaint alleges,  among other things,  that the defendants
violated the "anti-kickback"  statute in part because a portion of the Company's
fee was based on the  number of new  patients  seen in the  wound  care  centers
managed  by the  Company;  engaged  in  prohibited  self-referral  transactions;
improperly  billed  Medicare  for costs and  services  not covered by  Medicare;
double-billed  Medicare for professional services; and submitted false claims to
Medicare.  Certain of the  allegations  are similar to the  allegations  made in
United  States ex. Rel.  Joseph  "Mickey"  Parslow v.  Columbia/HCA  Health Care
Corporation   and   Curative   Health    Services,    Inc.,   Civil   Case   No.
98-1260-civ-T-23F,  in the  Federal  District  Court for the Middle  District of
Florida,  Tampa Division, a qui tam action previously disclosed in the Company's
Form 10-Q for the quarter  ended March 31, 1999.  The  complaint in the Southern
District of New York action asserts that, as a result of the allegedly  wrongful
conduct,  the United States suffered  damages and that the defendants are liable
to the United  States for three  times the amount of the  alleged  damages  plus
civil penalties of up to $10,000 per false claim.

The United  States has not yet decided  whether to intervene in the New York qui
tam action.  If it does not, then the plaintiff relator may pursue the claims on
his/her own or may withdraw the complaint.

The  Company  disagrees  with  the  characterizations  in the  complaint  of its
contractual  arrangements,  its  services,  and the fees it  charges  for  those
services,  and intends to defend itself  vigorously  in this action.  An adverse
result  in this qui tam  action  could  have a  material  adverse  effect on the
Company's business, financial condition and/or results of operations.

                                       2
Item 7.  Financial Statements and Exhibits

(a) (b)  No financial statements or proforma financial information filed herein.

(c)      No exhibits are filed as part of this Report.

                                       3
SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned, thereunto duly authorized.

                                   Curative Health Services, Inc.
                                  (Registrant)

Date:  January 12, 2000            By:  /s/John C. Prior
                                        --------------------------------
                                        John C. Prior
                                        Senior Vice President/Finance and CFO